RE:RE:RE:RE:RE:New Corporate PresentationNo one finances someone else for free, so there will be dilution. The financing is for an acquisition. There is no mention of any financing required for other operations, so we don't know what their internal forecast is yet. The $3M per product per year is probably all the exchange allows kne to say publicly at this stage, but that doesn't prove kne thinks that's the maximum they will get.
Does any shareholder think each product will get exactly the same revenue? No. So I think kne has a different internal forecast for now.